This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Meclofenoxate
- DrugBank Accession Number
- DB13758
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for Meclofenoxate (DB13758)
- Weight
- Average: 257.71
Monoisotopic: 257.0818711 - Chemical Formula
- C12H16ClNO3
- Synonyms
- Meclofenoxate
- External IDs
- ANP-235
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- ATC Codes
- N06BX01 — Meclofenoxate
- Drug Categories
- Acetates
- Acids, Acyclic
- Central Nervous System Agents
- Compounds used in a research, industrial, or household setting
- Glycolates
- Hydroxy Acids
- Nervous System
- Neuroprotective Agents
- Nootropic Agents
- Phenoxyacetates
- Protective Agents
- Psychoanaleptics
- Psychostimulants, Agents Used for ADHD and Nootropics
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as phenoxyacetic acid derivatives. These are compounds containing an anisole where the methane group is linked to an acetic acid or a derivative.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Benzene and substituted derivatives
- Sub Class
- Phenoxyacetic acid derivatives
- Direct Parent
- Phenoxyacetic acid derivatives
- Alternative Parents
- Phenoxy compounds / Phenol ethers / Chlorobenzenes / Alkyl aryl ethers / Aryl chlorides / Trialkylamines / Carboxylic acid esters / Amino acids and derivatives / Monocarboxylic acids and derivatives / Organopnictogen compounds show 4 more
- Substituents
- Alkyl aryl ether / Amine / Amino acid or derivatives / Aromatic homomonocyclic compound / Aryl chloride / Aryl halide / Carbonyl group / Carboxylic acid derivative / Carboxylic acid ester / Chlorobenzene show 17 more
- Molecular Framework
- Aromatic homomonocyclic compounds
- External Descriptors
- monocarboxylic acid (CHEBI:6712)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- C76QQ2I0RG
- CAS number
- 51-68-3
- InChI Key
- XZTYGFHCIAKPGJ-UHFFFAOYSA-N
- InChI
- InChI=1S/C12H16ClNO3/c1-14(2)7-8-16-12(15)9-17-11-5-3-10(13)4-6-11/h3-6H,7-9H2,1-2H3
- IUPAC Name
- 2-(dimethylamino)ethyl 2-(4-chlorophenoxy)acetate
- SMILES
- CN(C)CCOC(=O)COC1=CC=C(Cl)C=C1
References
- General References
- Not Available
- External Links
- KEGG Compound
- C08195
- ChemSpider
- 3899
- 2228
- ChEBI
- 6712
- ChEMBL
- CHEMBL64545
- ZINC
- ZINC000001531029
- Wikipedia
- Meclofenoxate
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count Not Available Unknown Status Treatment Coenzyme Q10 / Hepatic Encephalopathy (HE) / Intellectual Functioning Disability 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 2.9 mg/mL ALOGPS logP 2.4 ALOGPS logP 2.06 Chemaxon logS -2 ALOGPS pKa (Strongest Basic) 8.42 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 38.77 Å2 Chemaxon Rotatable Bond Count 7 Chemaxon Refractivity 66.2 m3·mol-1 Chemaxon Polarizability 26.87 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Drug created at June 23, 2017 20:48 / Updated at February 21, 2021 18:54